NATIONAL

US FDA Wants COVID Boosters Targeting Omicron BA.4, BA.5 Subvariants

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020.
The U.S. Food and Drug Administration on Thursday recommended COVID-19 vaccine manufacturers change the design of their booster shots beginning this fall to include components tailored to combat the currently dominant Omicron BA.4 and BA.5 subvariants of the coronavirus.
More news

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.